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Summary
Using oligonucleotide primers complementary to conserved regions in the mouse erythropoietin
(Epo) gene, a portion of the rat Epo gene was amplified by the polymerase chain reaction to
produce a probe suitable for assay of rat Epo mRNA by RNAse protection. The assay, which
has sufficient sensitivity to measure to Epo mRNA in unstimulated rat kidneys, was used to
demonstrate high amplitude in vitro modulation of Epo mRNA levels in response to changes
in perfusate flow rate and oxygen tension in isolated kidneys, thus providing clear evidence that
all the necessary events linking changes in oxygen delivery to the modulation of Epo mRNA
levels can occur intrarenally.
n early experiments, accumulation of erythropoietin (Epo)
in the perfusate of isolated kidneys provided important evi-
dence that the kidney is the site of synthesis (1, 2). These
experiments also suggested that the sensing mechanism was
intrarenal, since, in some studies, hypoxic perfusion was as-
sociated with an increased accumulation ofEpo in the perfu-
sate. Recent work (3-5) has shown that a major control mech-
anism for Epo synthesis operates by modulation of Epo
mRNA, mediated at least in part at the transcriptional level
(5). We therefore argued that if all components forming the
major link between blood oxygen availability and Epo syn-
thesis were intrarenal, then it should be possible to show
modulation of mRNA levels in isolated kidneys and to use
such a system to study the physiology of the sensing mecha-
nism. Unfortunately, studies using the relatively insensitive
method of Northern blotting have not been able to demon-
strate Epo mRNA in unstimulated kidneys, requiring inves-
tigators to apply relatively severe stimuli in vivo to bringEpo
mRNA levels into a detectable range (3-5).
To address this problem, we have used a sensitive RNAse
protection assay (6) for rat Epo mRNA. In this paper, we
describe the detection of Epo mRNA in unstimulated rat
kidneys, the quantitation ofmRNA levels using (3 cytoplasmic
actin as an internal control, and the application ofthis method
to the isolated perfused rat kidney to demonstrate in vitro
modulation of mRNA levels in response to changes in oxy-
gen delivery.
Materials and Methods
KidneyPerfusion.
￿
Isolated kidneys from male Wistar rats (330-
390 g) were perfused in a recirculating circuit using modifications
of the technique described by Ross et al. (7) . Kidneys were per-
fused for 2 h at constant perfusate flow, whichwas achieved through
feedback control ofthe perfusion pressure. The perfusate consisted
of Krebs-Henseleit buffer containing 3 or 5% BSA (Fraction V;
Miles Laboratories, Slough, UK) supplemented with washed human
erythrocytes (final haematocrit 0.11-0.16, glucose, 5 mmol/liter),
and the 20 physiological amino acids. '°C-inulin (Amersham In-
ternational, Amersham, UK) was added to permit measurement
of glomerular filtration rate by inulin clearance. Oxygen tensions
were measured using an ABIr3 blood gas analyzer (Radiometer,
Copenhagen, Denmark). All experiments were performed with
erythrocytes from a single donor. Hemoglobin-bound oxygen con-
tent (,umol/ml) was calculated using the formula: 0.62x [satura-
tion (fractional) x hemoglobin (g/dl)] . The dissolved oxygen con-
tent of the perfusate was calculated according to the formula:
02 content (iAmol/ml) = 1.257 x 10-3 x [p02 (mmHg) x
(1-haemacrit].
RNAse Protection Assay.
￿
Kidneys were homogenized in guani-
dine thiocyanate, and RNA was purified on a cesium chloride gra-
dient. The fully complementary genomic probe used as the tem-
plate for production of the labeled RNA transcripts necessary in
the RNAse protection assay was obtained by amplification of rat
genomic DNA using oligonucleotides complementary to conserved
regions in exons IV and V of the mouse sequence in the PCR.
From the amplification product, a PstI/SacI fragment, containing
132 by of exon V and -300 by of the intron extending 5' to this
sequence, was constructed and inserted into pSP64 for generation
ofthe RNA transcripts. A partial nucleic acid sequence ofthis probe
was determined by the dideoxy chain termination method. The
actin probe was constructed from a genomic clone of the rat cyto-
plasmic (3-actin gene, which was generously donated by Dr. Uri
Nudel of the Weizman Institute of Science, Rehovot, Israel. An
AvaI/HindIII fragment containing the 76 nucleotidefirst exon and
-200 by of surrounding sequence was inserted into pAM19. Sample
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equivalent specific activity, actin and erythropoietin probes used
on a single sample ofRNA were always made from the same source
of a[32P]GTP. For analysis of erythropoietin mRNA, an aliquot
of total RNA was dissolved in hybridization buffer consisting of
80%formamide, 40 mmol/l Pipes, pH 6.4, 400mmol/liter NaCl,
and1 mmol/l EDTA. Hybridization wasperformedat 60°Cusing
a 50-/Al aliquot, containing 250 hg total RNA and 0.5-1 x 106
cpm radiolabeled erythropoietin probe. RNAsedigestion wasper-
formed at 20°C for30 min, andthe protected fragmentswere run
on a denaturing 10%polyacrylamide gel. Fornormalization to the
R-cytoplasmic actinsignal, an aliquot oforiginal solution of RNA
in hybridization buffer was further diluted to a concentration of
0.05 Fog/gl, and a parallel hybridization was performed at 60°C
using a 50-Al aliquot, containing 2.5 jig total RNA and 2-2.5 x
106 cpm radiolabeled actin probe. After RNAsedigestion at 20°C
for 30 min, one-tenth of the products were added to the
erythropoietin analysis so that subsequent purification and gelelec-
trophoresis were performed together. X-ray film was exposed to
the dried gels at -70°C, after which the protected bands were
excised from the gel, set in solid scintillant, and counted using a
flat matrix fi counter (1205; Pharmacia/LKB, Inc., Gaithersburg,
MD). Kendall'stauwas calculated to test thesignificance ofassoci-
ations between variables.
Results
DNA sequence analysis of the rat genomicerythropoietin
probe demonstrated a very high degree of homology with
The Epo mRNA values are the mean of duplicate measurements and refer to the abundance relative to Actin mRNA . Epo mRNA was nega-
tively associated with perfusate flow rate in both groups (P < 6.05). Oxygen consumption was positively associated with perfusate flow rate
(p < 0.05) in both groups.
658
￿
Oxygen-Dependent Modulation of Erythropoietin mRNA Levels
the mouse, and the mobility of the protected fragment was
exactly that expected from conservation of the splice site be-
tween exons 4 and 5.
Using 250 hg of total RNA, erythropoietin mRNA was
readily detected in kidneys from normal animals. Compar-
ison with the signal from 0cytoplasmic actinmRNA showed,
nevertheless, that thelevel of erythropoietin mRNA was very
low in these unstimulated kidneys. Allowing forthe different
guanosine contents of the protected erythropoietin probe frag-
ment andactin fragment, the ratio oferythropoietin mRNA
to 13 cytoplasmic actin mRNA is -1:10,000. During 2 h of
isolated kidney perfusion, the level of actin mRNA did not
change, and this was used as an internal control for the semi-
quantitative estimate of Epo mRNA.
Demonstration ofModulation of Epo mRNA in Isolated
Kidneys. During isolated perfusion for 2 h with medium
containing erythrocytes at a hematocrit of 11-16%, a striking
increase in Epo mRNA was seen under appropriate condi-
tions. To be sure that the stimulation of Epo mRNA ob-
served in perfused kidneys did not occur during surgical dis-
section for the perfusion nephrectomy, the contralateral left
kidney was removed and homogenized for RNA extraction
immediately aftercommencing perfusion of theright kidney.
Thesekidneys contained similar levels ofEpo mRNA to those
in kidneys taken immediately from unstimulated animals.
To analyze some characteristics of the in vitro response of
Table 1. Functional Parameters for Isolated Kidneys
Epo mRNA
Base- Perfused Hct 02 Venous 02
Exp. line kidney Flow (fractional) PA02 delivery PV02 saturation consumption GFR FRNa
x 1lr° mllmin mmHg 'Umollmin mmHg % umollmin mllmin
1 - 21 .4 4 0.16 152 15.5 56 87 2.03 0.55 86.4
2 - 15 .4 5 0.16 164 17.8 61 89 2.24 - -
3 0.54 9.12 5 0.13 171 14.4 57 87 2.09 0.17 80.0
4 0.33 26 .2 5 0.13 158 14.2 72 93 1.28 - -
5 1.16 9.84 12 0.15 158 37.0 68 93 3.29 0.70 87.6
6 1.37 6.40 15 0.12 171 40.7 68 93 4.00 0.73 88.3
7 0.82 2.79 18 0.11 148 43.7 62 89 5.85 1.51 90.3
8 1.31 2.46 20 0.16 140 71 .3 70 93 5.64 1.76 75.7
9 0.69 0.58 25 0.13 143 74.0 73 93 6.19 0.79 98.6
10 1.57 9.04 5 0.15 374 28.4 81 94 2.55 - -
11 0.48 1.58 12 0.13 367 36.8 160 99 3.03 0.73 99.0
12 0.67 0.19 12 0.15 427 42.7 174 99 3.64 - -
13 0.64 1.04 15 0.16 423 54.9 152 99 4.88 1.18 93.2
14 0.59 0.31 18 0.15 406 63.5 160 99 5.46 1.52 86.1
15 1.03 0.33 20 0.11 387 53.6 163 99 5.31 1.07 92.4Epo mRNA to oxygen delivery, 15 experiments were per-
formed at different perfusate flow rates and oxygen tensions
(Table 1) . In all kidneys, renal oxygen delivery and consump-
tion were stable for duration of the experiment . The Epo
mRNA to (3 ActinmRNA ratio was 0.86 ± 0.39 x 10-a
SD in the contralateral control kidneys. The modulation of
EpomRNA was dependent on perfusate flow rate (Table 1) .
Fig. 1 shows the results for four experiments conducted in
the low p02 range, using 20% 02, 75% N2, 5% C02 to
gas the perfusate. The 20-40-fold increase in Epo mRNA
that occurred at a perfusate flow rate of 5 ml/min was re-
duced as perfusate flow rate was increased . In the high p02
range obtained by gassing the perfusate with 95% 02, 5%
C02, only the lowest flow rate studied caused significant
stimulation ofEpo mRNA . Fig. 2 shows theRNA analysis
from two pairs of kidneys perfused at the similar flow rates
but high or low oxygen tensions, and demonstrates the de-
pendence ofEpomRNA modulation on perfusate p02 . In
kidneys perfused at high flow rate and high oxygen tension,
Epo mRNA was lower than in the contralateral control kidney.
Figure 1 .
￿
RNAse protection analysis ofmRNA from four isolated
kidneys perfused at oxygen tensions in the lower range (143-171
mmHg), but at different flow rates. The four lanes on the left contain
mRNA from the contralateral (unstimulated) kidney removed at the
start of perfusion . The Epo signal arises from 250 pg total RNA,
and the actin signal arises from 250 ng total RNA . Size markers
were generated by a Hpall digest of pBR322 DNA . The autoradio-
graph was exposed at -70°C for 14 h .
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This assay was capable of detecting Epo mRNA for the
first time in unstimulated rat kidneys, a result in keeping with
the existence of a basal circulating level of the hormone and
the established view of the kidney as the principal site of syn-
thesis.
The demonstration of high amplitude modulation of
erythropoietin mRNA levels in isolated kidneys provides clear
evidence that all the necessary events linking changes in oxy-
gen delivery to the modulation ofEpo mRNA levels can occur
intrarenally. This result is consistent with the demonstration
of oxygen-dependent synthesis of erythropoietin by certain
cell lines derived from malignant tissues, notably hepatoma
(8), and is also consistent with the results of studies on iso-
lated perfused kidneys in which a greater accumulation of
erythropoietin was observed during hypoxia (2, 9) . One
difficulty, however, with measurement of erythropoietin
production itself in isolated kidney perfusion experiments,
has been that the time required to accumulate measurable
quantities in the perfusate is long in relation to the viability
of the preparations . Modulation ofEpomRNA, since it occurs
earlier, allows reduction of the perfusion time to a period
well within the limits of stability of this preparation . Fur-
thermore, by measurement of EpomRNA in the contralateral
kidney at the start ofperfusion, it was possible to prove that
Figure 2 .
￿
RNAse protection analysis of mRNA from isolated kid-
neys. Pairs of kidneys were perfused at similar flow rates but different
oxygen tensions . The Epo signal arises from 250 Wg total RNA, and
the actin signal arises from 250 ng total RNA . The autoradiograph
was exposed at -70°C for 8 h .modulation of Epo mRNA occurred during isolated perfu-
sion and not during the dissection for perfusion nephrectomy.
The responses of the perfused kidney to changes in perfu-
sate p02 and perfusate flow rate are consistent with in vivo
regulation of erythropoietin synthesis, although reduction
in erythropoietin synthesis by increasing renal blood flow has
not been described in vivo. In a recent study on the rat, it
was shown that reduction of renal blood flow by constric-
tion of the renal artery increased erythropoietin synthesis,
to a much lesser extent than anemia (10). The authors ofthat
study offered two explanations for the result, first, that the
major mechanism linking Epo production to blood oxygen
availability might require an extrarenalcomponent, and second,
that the changes in intrarenal oxygenation might differ be-
tween the two stimuli because of the interdependence of
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